LifeScience Alley Announces New Appointments
News May 30, 2013
LifeScience Alley announces the election of the following officers to its board of directors: Kathleen Chester, vice president of global regulatory affairs and corporate officer, St. Jude Medical, Inc.; Todd Fruchterman, MD, PhD, senior vice president of research and development and regulatory affairs, chief technology officer and chief medical officer, 3M Health Care; Brian Herman, PhD, vice president for research, University of Minnesota; Rick Kuntz, MD, senior vice president for strategy and scientific operations, chief scientific, clinical and regulatory officer, Medtronic, Inc. and Jeff Mirviss, senior vice president and president, Peripheral Interventions, Boston Scientific Corporation. In addition, current board vice chair Stephen Snyder - vice president marketing, Cargill Industrial Oils & Lubricants - has been elected to serve as chairman of the board of directors. Outgoing chairman, Steve Mertens, senior vice president of operations, Holaira, Inc., has been elected to serve as vice chair.
"We are very excited to announce the addition of these officers to LifeScience Alley's board of directors," states Steve Mertens, outgoing chairman of the board. "As our organization continues to strengthen our impact on the national and international operating environment for our members, direction from thought leading individuals and organizations like these is critical."
The election of these high-level industry executives underscores the organization's strategic commitment to providing its members and community with expanded leadership and support at a critical time. Many sectors of the life sciences industries are undergoing economic and policy-based shifts directly affecting business innovation and growth. LifeScience Alley and its subsidiaries, in accordance with their mission, are focused on advocating for sound public policy and engaging in special projects to develop and grow the industries that will ensure Minnesota's leadership in the global life science ecosystem.
Tailor-made Protein Fights Several Species of BacteriaNews
As resistance to existing antibiotics increases, new approaches to serious bacterial infections are needed. Now researchers have investigated one such alternative.READ MORE
First Successful Gene Therapy Trial Reported for People with Hemophilia ANews
Patients with hemophilia A who received a single infusion of an investigational gene therapy showed improved levels of the essential blood clotting protein FVIII, with 11 of 13 achieving normal or near-normal FVIII levels.READ MORE